Posted by ipeg on April 23rd, 2011
In the rapidly changing economy of today, the tangible property of a company is becoming less important than an intangible property which is very often a company’s most important, if not the only, valuable asset. Nora Wouters highlights the possibilities and limitations under Belgian regulatory legal framework to use IPRs as collateral or a securitisation asset.
The advantages for the debtor and the creditor when using IP rights as collateral
The UNCITRAL Legislative Guide on Secured Transactions (the ‘Guide’) emphasises the importance...
Posted by ipeg on August 15th, 2010
IP rights are frequently used as security to enable financing of business ventures. However how does this work out for the different legal systems in the world? What are the effects on third parties like banks and financial institutions? One of the essential characteristics of IP rights is their ability to be used commercially by assignment or licensing. The economic importance of the licensing agreements is very significant.
In 2006 the AIPPI -an international intellectual property lobby association – received 44 reports from countries...
Posted by ipeg on July 31st, 2009
After the financial crisis and subsequent downturn of the economy as a whole one would think that old school financial products are “out” and financial creativity is “in”. However, Morgan Stanley unveiled earlier this month a US$ 250 million IP securitization for Vertex Pharmaceuticals, a US biotech company that would see investors repaid from contractual milestone payments on a drug still in development. Old habits die hard, despite an almost freeze in securitization markets in 2008 and early 2009 that led to a dramatic shortage...
European IP Case Law (IPPT)